Clinical trials data
Verbal Fluency in brain injury and concussion trials: 86 registered studies
Every registered brain injury and concussion study on ClinicalTrials.gov that names Verbal Fluency in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered brain injury and concussion studies name it in an outcome measure
- 86
- Name it in a primary outcome, 45%
- 39 of 86
Tests named in the same studies
- 1
Trail Making Test48 studies, 21 as a primary outcome
- 2
Verbal Learning42 studies, 22 as a primary outcome
- 3
Digit Span Test34 studies, 14 as a primary outcome
- 4
Stroop Color-Word Test22 studies, 10 as a primary outcome
- 5
Category Fluency20 studies, 12 as a primary outcome
- 6
Symbol Coding16 studies, 5 as a primary outcome
- 7
Picture Naming Test12 studies, 5 as a primary outcome
- 8
Symbol Scan Task11 studies, 4 as a primary outcome
- 9
Complex Figure Copy and Recall10 studies, 1 as a primary outcome
- 10
Paced Visual Serial Addition Test9 studies, 7 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 2 | 2 |
| 2008 | 1 | 1 |
| 2009 | 3 | 1 |
| 2010 | 0 | 0 |
| 2011 | 4 | 2 |
| 2012 | 3 | 1 |
| 2013 | 6 | 3 |
| 2014 | 2 | 0 |
| 2015 | 2 | 2 |
| 2016 | 5 | 1 |
| 2017 | 5 | 1 |
| 2018 | 4 | 0 |
| 2019 | 6 | 3 |
| 2020 | 7 | 3 |
| 2021 | 7 | 5 |
| 2022 | 2 | 1 |
| 2023 | 7 | 6 |
| 2024 | 5 | 2 |
| 2025 | 9 | 4 |
| 2026 | 4 | 1 |
Phases and study sizes
By phase
- Phase 14 studies, 3 as a primary outcome
- Phase 1/22 studies, 1 as a primary outcome
- Phase 28 studies, 2 as a primary outcome
- Phase 35 studies, 1 as a primary outcome
- Phase 42 studies, 0 as a primary outcome
- Not applicable57 studies, 28 as a primary outcome
- Observational8 studies, 4 as a primary outcome
Participants per study
- Not applicable36 median, 24 to 72
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 57 | 36 | 24 to 72 |
When brain injury and concussion trials measure it
Latest time point of each outcome
- Within a day12 outcomes, 6 as a primary outcome
- Up to 4 weeks9 outcomes, 5 as a primary outcome
- 1 to 3 months33 outcomes, 13 as a primary outcome
- 3 to 6 months18 outcomes, 9 as a primary outcome
- 6 to 12 months6 outcomes, 3 as a primary outcome
- 1 to 2 years3 outcomes, 0 as a primary outcome
- Over 2 years1 outcomes, 1 as a primary outcome
- No duration given4 outcomes, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
82 of the 86 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting14 studies, 7 as a primary outcome
- Not yet recruiting4 studies, 1 as a primary outcome
- Active, not recruiting4 studies, 3 as a primary outcome
- Completed44 studies, 20 as a primary outcome
- Stopped early10 studies, 4 as a primary outcome
- Status unknown10 studies, 4 as a primary outcome
What they test
- Behavioral26 studies, 14 as a primary outcome
- Drug17 studies, 6 as a primary outcome
- Device24 studies, 12 as a primary outcome
- Procedure3 studies, 1 as a primary outcome
- Diagnostic test3 studies, 1 as a primary outcome
- Biological4 studies, 1 as a primary outcome
- Combination product1 studies, 0 as a primary outcome
- Other20 studies, 9 as a primary outcome
- None given1 studies, 0 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States59 studies, 28 as a primary outcome
- Italy6 studies, 1 as a primary outcome
- Canada4 studies, 3 as a primary outcome
- Spain3 studies, 2 as a primary outcome
- China1 studies, 0 as a primary outcome
- Cyprus1 studies, 1 as a primary outcome
- Denmark1 studies, 0 as a primary outcome
- France1 studies, 0 as a primary outcome
- Germany1 studies, 0 as a primary outcome
- Monaco1 studies, 1 as a primary outcome
- Norway1 studies, 0 as a primary outcome
- South Korea1 studies, 0 as a primary outcome
14 countries in all. A study with sites in several counts in each; 5 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed brain injury and concussion studies that name Verbal Fluency: 18 of 44, 41%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed brain injury and concussion studies that name Verbal Fluency | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 2, 5% | 776, 10% |
| Results on ClinicalTrials.gov only | 13, 30% | 1,139, 14% |
| A results paper only | 3, 7% | 1,711, 22% |
| Neither | 26, 59% | 4,327, 54% |
The 86 studies
86 studies match. 39 name Verbal Fluency in a primary outcome. Median size 43 participants. Median time to the primary outcome: 9 weeks.
Loading 86 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 2 | 2 |
| 2008 | 1 | 1 |
| 2009 | 3 | 1 |
| 2010 | 0 | 0 |
| 2011 | 4 | 2 |
| 2012 | 3 | 1 |
| 2013 | 6 | 3 |
| 2014 | 2 | 0 |
| 2015 | 2 | 2 |
| 2016 | 5 | 1 |
| 2017 | 5 | 1 |
| 2018 | 4 | 0 |
| 2019 | 6 | 3 |
| 2020 | 7 | 3 |
| 2021 | 7 | 5 |
| 2022 | 2 | 1 |
| 2023 | 7 | 6 |
| 2024 | 5 | 2 |
| 2025 | 9 | 4 |
| 2026 | 4 | 1 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 5, NIH 1, other 80. Interventional 78, observational 8.
As a primary outcomeSecondary or other outcomeVerbal Fluency
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07867015 | Start2026 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants30 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07702513 | Start2026 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants33 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07456475 | Start2025 | PhaseNot applicable | ConditionsStroke, Brain injury and concussion, Parkinson's disease, Multiple sclerosis | Participants25 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07413562 | Start2025 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07190365 | Start2026 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07119827 | Start2025 | PhaseObservational | ConditionsStroke, Brain injury and concussion | Participants250 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07025317 | Start2024 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants200 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06989970 | Start2026 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants20 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06956404 | Start2025 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants70 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06920784 | Start2024 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants50 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06897553 | Start2024 | PhaseNot applicable | ConditionsBrain injury and concussion, Depression and bipolar disorder, COVID-19 and long COVID, Anxiety, PTSD and OCD | Participants44 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06871124 | Start2025 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06848140 | Start2025 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants24 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06840808 | Start2024 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants14 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06562127 | Start2025 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06556316 | Start2020 | PhaseObservational | ConditionsStroke, Brain injury and concussion | Participants200 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06494592 | Start2023 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants37 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06217575 | Start2025 | PhaseNot applicable | ConditionsBrain injury and concussion, Aging, frailty and exercise | Participants36 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06130735 | Start2023 | PhaseNot applicable | ConditionsMild cognitive impairment, Brain injury and concussion | Participants30 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT05970575 | Start2023 | PhasePhase 2 | ConditionsBrain injury and concussion | Participants4 | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT05951777 | Start2024 | PhasePhase 2 | ConditionsStroke, Brain injury and concussion, Cancer | Participants51 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT05819008 | Start2023 | PhaseObservational | ConditionsStroke, Brain injury and concussion, Parkinson's disease, Multiple sclerosis, Cancer, Epilepsy | Participants350 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05756296 | Start2023 | PhaseObservational | ConditionsBrain injury and concussion | Participants198 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT05561400 | Start2023 | PhaseNot applicable | ConditionsStroke, Brain injury and concussion | Participants10 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05408975 | Start2023 | PhaseNot applicable | ConditionsBrain injury and concussion | Participants5 | Lead sponsorOther | StatusCompleted | Library tests named
|
Questions, answered from the data
How many brain injury and concussion trials use Verbal Fluency?
86 registered brain injury and concussion studies on ClinicalTrials.gov name it in an outcome measure, 39 of them in a primary outcome: 19% of the condition's 444 studies with a cognitive outcome, against 11% of all of them. It is the 4th most named test in brain injury and concussion trials.
Which tests do brain injury and concussion trials use with Verbal Fluency?
The Trail Making Test (48 studies), Verbal Learning (42 studies) and the Digit Span Test (34 studies).
When do brain injury and concussion trials measure Verbal Fluency?
Half of the primary outcomes that name Verbal Fluency are measured within 9 weeks of the start, and the middle half from 1 week to 6 months. 37 primary outcomes give a duration.
How many completed brain injury and concussion trials that use Verbal Fluency have reported results?
18 of the 44 completed studies that name it, 41%, have reported results: 15 posted them on ClinicalTrials.gov, 5 have a results paper linked to the registry record, and 2 did both. The other 26 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run Verbal Fluency in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.